CorMedix, Inc. (CRMD)

NYSE MKT - NYSE MKT Real Time Price. Currency in USD
1.61-0.08 (-4.73%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close1.69
Bid1.64 x 900
Ask2.62 x 300
Day's Range1.60 - 1.68
52wk Range1.15 - 4.54
1y Target EstN/A
Market Cap60.05M
P/E Ratio (ttm)-3.24
Avg Vol (3m)334,796
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • A Look at Billionaire Paul Singer’s Long-Term Investments
    Insider Monkey7 days ago

    A Look at Billionaire Paul Singer’s Long-Term Investments

    Activist investor and billionaire hedge fund manager Paul Singer was awarded this year’s Manager Lifetime Achievement Award by the Institutional Investor magazine in New York in June. In his nearly four-decade-long career as a fund manager, Mr. Singer has seen various and ups-and-downs in the market, but has still managed to consistently generate superior returns […]

  • Accesswire8 days ago

    CorMedix Inc. Invited to Present at Two Upcoming Scientific Conferences

    BEDMINSTER, NJ / ACCESSWIRE / August 16, 2016 / CorMedix Inc . (NYSE MKT: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment ...

  • Capital Cube11 days ago

    ETF’s with exposure to CorMedix, Inc. : August 12, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to CorMedix, Inc. Here are 5 ETF’s with the largest exposure to CRMD-US. Comparing the performance and risk of CorMedix, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)